300584.SZ
Nanjing Hicin Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 32.79
−0.33%Aug 24, 2026, 10:13 UTC
Haishen Pharmaceutical announced its 2026 first-half results: net profit attributable to shareholders was 32.065 million yuan, up 9.97% year-on-year.